Human Papilloma Virus in Head and Neck Cancers-Role and Relevance in Clinical Management

Indian Journal of Surgical Oncology

Volumn 4, Issue 1, 2013, Pages 59-66

  Ramshankar, Vijayalakshmi ^a   Krishnamurthy, Arvind ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Head and neck squamous cell carcinoma; HPV status; Prognostic indicators; Tumorigenesis mechanism in HPV positive head and neck cancers

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL VECTOR; CANCER VACCINE; DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MOLECULAR MARKER; NEUTRALIZING ANTIBODY; PEPTIDE VACCINE; PROTEIN P16; PROTEIN P53; VIRUS VECTOR; WART VIRUS VACCINE;

CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE G2 PHASE; CHEMORADIOTHERAPY; DNA VIRUS; FALSE POSITIVE RESULT; G2 PHASE CELL CYCLE CHECKPOINT; GENE DOSAGE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IN SITU HYBRIDIZATION; INFECTION RISK; M PHASE CELL CYCLE CHECKPOINT; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; OROPHARYNX CANCER; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; REVIEW; SEXUALLY TRANSMITTED DISEASE; TONSIL CANCER; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS INFECTION; VIRUS ONCOGENE; WART VIRUS;

EID: 84874380378     PISSN: 09757651     EISSN: 09766952     Source Type: Journal    
DOI: 10.1007/s13193-012-0196-5     Document Type: Review

References (48)

1. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB (2006) Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 6: 1111-1118.
2. Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J (1983) Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12: 418-424.
3. Shin KH, Min BM, Cherrick HM, Park NH (1994) Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinog 9: 76-86.
4. zur Hausen H, de Villiers EM, Gissmann L (1981) Papillomavirus infections and human genital cancer. Gynecol Oncol 12: 124-128.
5. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J ClinPathol 55: 244-265.
6. Miller CS, Johnstone BM (2001) Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 91(6): 622-635.
7. Ha PK, Califano JA (2004) The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med 15: 188-196.
8. Human papilloma viruses (2007) IARC Monogr Eval Carcinog Risks Hum 90: 1-636.
9. Hansson BG, Rosenquist K, Antonsson A, Wennerberg J, Schildt EB, Bladström A, Andersson G (2005) Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 125: 1337-1344.
10. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14: 467-475.
11. Thavaraj S, Stokes A, Guerra E, Bible J, Halligan E, Long A, Okpokam A, Sloan P, Odell E, Robinson M (2011) Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 64: 308-312.
12. Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparén P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T (2006) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125: 362-366.
13. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus (HPV) and rising oropharyngeal cancer incidence and survival in the United States. J Clin Oncol 29: 4294-4301.
14. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papilloma virus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26: 612-619.
15. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 113: 2901-2909.
16. Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M (2010) Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 116: 2635-2644.
17. Hocking JS, Stein A, Conway EL, Regan D, Grulich A, Law M, Brotherton JM (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104: 886-891.
18. Pierce JP, Messer K, White MM, Cowling DW, Thomas DP (2011) Prevalence of heavy smoking in California and the United States, 1965-2007. JAMA 305: 1106-1112.
19. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU et al (1995) Human papilloma virus in 91 oral Indian betel quid chewers: High prevelance and multiplicity of infections. Int J Cancer 61: 450-454.
20. D'Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR (1998) Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34: 413-420.
21. Nagpal JK, Patnaik S, Das BR (2002) Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 10(97): 649-653.
22. Pillai MR, Nair MK (2000) Development of a condemned mucosa syndrome and pathogenesis of human papilloma virus-associated upper aerodigestive tract and uterine cervical tumors. Exp Mol Pathol 69: 233-241.
23. Agius PA, Pitts MK, Smith AM, Mitchell A (2010) Sexual behaviour and related knowledge among a representative sample of secondary school students between 1997 and 2008. Aust N Z J Public Health 34: 476-481.
24. Aral SO, Patel DA, Holmes KK, Foxman B (2005) Temporal trends in sexual behaviors and sexually transmitted disease history among 18- to 39-year-old Seattle, Washington, residents: results of random digit-dial surveys. Sex Transm Dis 32: 710-717.
25. Bajos N, Bozon M, Beltzer N, Laborde C, Andro A, Ferrand M, Goulet V, Laporte A, Le van C, Leridon H, Levinson S, Razafindratsima N, Toulemon L, Warszawski J, Wellings K (2010) Changes in sexual behaviours: from secular trends to public health policies. AIDS 24: 1185-1191.
26. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123: 187-194.
27. Gillison ML (2009) Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol 21: 439-444.
28. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956.
29. Koskinen WJ, Chen RW, Leivo I, Mäkitie A, Bäck L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A, Aaltonen LM (2003) Prevalence and physical status of humanpapillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107(3): 401-406.
30. Syrjanen S (2004) HPV infections and tonsillar carcinoma. J Clin Pathol 57: 449-455.
31. Braakhuis BJM, Snijders PJF, Keune W-JH, Meijer CJLM, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH (2004) Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96(13): 998-1006.
32. Zheng ZM, Baker C (2006) Papillomavirus genome structure, expression and post translational regulation. Front Biosci 11: 2286-2302.
33. Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta analysis. Int J Cancer 121: 1813-1820.
34. Smith EM, Rubenstein LM, Haugen TH, Pawlita M, Turek LP (2012) Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012: 571862.
35. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35.
36. Attner P, Du J, Näsman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E (2010) The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 126: 2879-2884.
37. Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI (2008) Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 119: 1542-1549.
38. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269.
39. Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ (2009) Winquist EW Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol 20: 921-927.
40. Pang E, Delic NC, Hong A, Zhang M, Rose BR, Lyons JG (2011) Radiosensitization of oropharyngeal squamous cell carcinoma cells by human papillomavirus 16 oncoprotein E6*I. Int J Radiat Oncol Biol Phys 79: 860-865.
41. Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, Corry J, Lim A, Waldeck K, Solomon B (2011) Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 20: 1230-1237.
42. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102: 152-158.
43. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A (2006) Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24: 736-747.
44. Mehanna H, Olaleye O, Licitra L (2012) Oropharyngeal cancer - is it time to change management according to human papilloma virus status? Curr Opin Otolaryngol Head Neck Surg 20: 120-124.
45. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bauer JA, Bradford CR, Carey TE (2008) EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26: 3128-3137.
46. Hong A, Dobbins T, Lee CS, Jones D, Jackson E, Clark J, Armstrong B, Harnett G, Milross C, O'Brien C, Rose B (2010) Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer 46: 2088-2096.
47. Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113: 3036-3046.
48. Wu AA, Niparko KJ, Pai SI (2008) Immunotherapy for head and neck cancer. J Biomed Sci 15: 275-289.